Serina Therapeutics SER
NYSE SER
$1.96 -0.03 (-1.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Serina Therapeutics (SER) Return on Equity [ROE] (2018 - 2026)

Updated

Serina Therapeutics' Return on Equity [ROE] came in at -222.00% for Q2 2026, up 567.58 percentage points from -789.58% a year earlier.

Analysis

Serina Therapeutics (SER) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Serina Therapeutics' Return on Equity [ROE] was -8159.24%.

  • The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 25.32%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 84.40%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 21.39%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 83.75%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -18.38%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 4.97%
10 Serina Therapeutics 32.61 Mn -8.13 Mn - -222.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -222.00%
Dec 31, 2025 -2,230.41%
Sep 30, 2025 -1,094.01%
Jun 30, 2025 -789.58%
Mar 31, 2025 -98.11%
Mar 31, 2020 -1,105.71%
Dec 31, 2019 -327.62%
Sep 30, 2019 -209.18%
Jun 30, 2019 -135.65%
Mar 31, 2019 -116.34%
Dec 31, 2018 -81.52%
API Access

Serina Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SER&period=max&api_key=YOUR_API_KEY